NewAmsterdam Pharma Company NAMS Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by NewAmsterdam Pharma Company in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about NewAmsterdam Pharma Company's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NewAmsterdam Pharma Company's total current assets?
- NewAmsterdam Pharma Company (NAMS) reported total current assets of $658.04M in Q1 2026.
- How has NewAmsterdam Pharma Company's total current assets changed year-over-year?
- NewAmsterdam Pharma Company's total current assets decreased by 19.5% year-over-year, from $817.3M to $658.04M.
- What is the long-term trend for NewAmsterdam Pharma Company's total current assets?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's total current assets has grown at a 12.2% compound annual growth rate (CAGR), from $477.98M to $675.7M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.